BDBM50593313 CHEMBL5192063

SMILES COc1ccc(Nc2ncc(C)c(Nc3ccc4oc(=O)[nH]c4c3)n2)cc1C(F)(F)F

InChI Key InChIKey=XHYLXFXKSYLIKT-UHFFFAOYSA-N

Data  4 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 4 hits for monomerid = 50593313   

TargetJAK3/JAK1(Human)
Rigel Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50593313(CHEMBL5192063)
Affinity DataIC50: 38nMAssay Description:Inhibition of JAK1/JAK3 in human primary T-cells assessed as reduction of IL-2 stimulated STAT5 phosphorylation preincubated for 1 hr followed by IL-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2023
Entry Details
PubMed
TargetCytochrome P450 3A4(Human)
Rigel Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50593313(CHEMBL5192063)
Affinity DataIC50: 400nMAssay Description:Inhibition of CYP3A4 (unknown origin) in presence of NADPHMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2023
Entry Details
PubMed
TargetTyrosine-protein kinase JAK2(Human)
Rigel Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50593313(CHEMBL5192063)
Affinity DataIC50: 1.98E+3nMAssay Description:Inhibition of JAK2 signaling pathway in human CHEP cells assessed as inhibition of EPO-induced cell survival preincubated for 1 hr followed by EPO ad...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2023
Entry Details
PubMed
TargetCytochrome P450 3A4(Human)
Rigel Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50593313(CHEMBL5192063)
Affinity DataIC50: 4.80E+3nMAssay Description:Inhibition of CYP3A4 (unknown origin) in absence of NADPHMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2023
Entry Details
PubMed